Piramal Enterprises Ltd. has agreed to sell its healthcare analytics unit, Decision Resources Group, to U.S.-based Clarivate Analytics Plc for $950 million. The transaction is expected to be completed by February 28.

DRG specializes in creating patient-centric commercial strategies to help pharma, biopharma and medical technology companies to achieve commercial success in complex health markets. Revenue from the healthcare insights and analytics business was $187.3 million for the financial year ended March 31, 2019.



In its largest transaction, Piramal had acquired Decision Resources Group (DRG) in 2012, investing $650 million to diversify its business. 



Clarivate Analytics provides insights and analytics to help accelerate the pace of innovation in its target verticals. This acquisition will help it to improve the commercialization of life-changing therapies.



Jerre Stead, Clarivate’s executive chairman and chief executive officer said, “This is a milestone acquisition which doubles the size of the company’s life sciences business and increase the total revenue by 20 percent. The deal sets us up to become an essential, end-to-end, industry-leading data and analytics provider to the highly attractive life sciences ecosystem.”